Les virus sont les causes principales d’encéphalites et plus d’une centaine d’entre eux sont impliquées dans ces pathologies. Cependant, plus de 50% des encéphalites restent sans étiologie, dû en partie à des techniques de diagnostic mal adaptées ou à une méconnaissance de l’agent infectieux impliqué. Nous rapportons les cas de deux enfants d’une même famille qui ont développé une encéphalite nécrosante aiguë (ANE) conduisant à une hospitalisation de plusieurs semaines en soin intensif. Les virus communément recherchés dans les cas d’encéphalites n’ont pas été retrouvés chez ces patients. Par contre, la culture réalisée à partir des prélèvements d’urine des enfants et d’un prélèvement de gorge pour l’un des deux, a permis d’isoler un nouveau réovirus nommé MRV2Tou05. L’analyse moléculaire des 10 segments du génome viral a indiqué qu’un nouveau réovirus de sérotype 2 avait été isolé chez ces patients et qu’il s’agissait d’un virus réassortant entre une souche isolée de porc et une souche humaine. Le virus se réplique dans des cellules neuronales humaines et a été retrouvé par amplification de gène dans les prélèvements d’urine et dans certains prélèvements de sérum des deux enfants. De plus, une réponse anticorps spécifique dirigée contre MRV2Tou05 a été détectée dans les sérums des patients de l’étude alors qu’aucune réponse anticorps n’a été observée dans 40 sérums de donneurs sains. Toutes ces données sont en faveur de l’implication du nouveau réovirus isolé dans l’encéphalopathie observée. Des études supplémentaires réalisées in vivo dans un modèle animal permettront de mieux comprendre le rôle étiologique de ce nouveau réovirus dans les cas d’encéphalites / Viruses remain the main cause of Acute Encephalitis and more hundred of them are implicated in these pathologies. However, the etiologic agent is not determined in approximately 50% of cases, owed partially to not well adapted techniques of diagnosis or to misunderstanding of the involved infectious agent. We report the cases of two children in a same family who developed an acute necrotizing encephalopathy (ANE) leading to hospitalization in intensive care unit. Viruses commonly found in encephalitis were not detected in cerebrospinal fluid of these patients. However, a new reovirus strain of serotype 2, MRV2Tou05 was isolated from urine and throat swab samples on epithelium cells and was identified by electron microscopy and genome sequencing. Molecular characterization of its segmented genome indicates that MRV2Tou05 is a reassortant issued from swine and human strains. This new reovirus strain was directly detected by a specific sensitive molecular test in urine and serum samples from the two children. A specific antibody response directed against this new reovirus strain was detected in patient sera, whereas no response was observed in 38 healthy adult sera. Both its isolation and molecular detection from samples of the patients and the specific immune response toward this strain suggest an etiologic role of this reovirus in the ANE cases described herein. The reproduction of symptoms in an animal model will help understanding the exact role of this strain in ANE cases

T. gondii é um protozoário amplamente disseminado pelo mundo que pode causar doença em animais e humanos. A evolução e a gravidade da doença dependem de características genéticas do parasita e do hospedeiro. A prevalência varia geograficamente, em Erechim, RS, 88% da população é soropositiva e 18% destes apresentam toxoplasmose ocular (TO). A resposta imune humoral contra T. gondii é persistente em todas as fases da infecção. O objetivo deste retrospectivo estudo foi correlacionar a imunidade humoral e a resposta contra peptídeos cepa-específicos com a gravidade da TO em pacientes de Erechim. 327 amostras de soro foram testadas (ELISA) para a pesquisa dos isótipos específicos e contra peptídeos cepa-específicos de regiões polimórficas (GRA6 e GRA7) do parasita. Nossos resultados sugerem que IgG2 e IgG3 estão associados à infecção adquirida recente, porém não há associação entre os isótipos e a evolução clínica da TO. Entretanto, embora seis diferentes sorotipos infectem estes pacientes, a gravidade da TO está associada a um novo padrão sorotípico (Atípico D). / T. gondii is a widespread protozoan parasite that is associated with a large spectrum of diseases in both humans and animals. The progression and severity of disease is quite variable and presumably due to some combination of host and parasite genetics. Prevalence varies with geography. In Erechim, Brazil, it is 88% prevalent and is related with a high incidence (18%) of ocular toxoplasmosis (OT). Humoral immune response against the parasite is effective. The aim of this retrospective study was to correlate the humoral immunity and response against the strain-specific peptides with the severity of the TO in Erechim`s patients. 327 sera were evaluated by ELISA to isotypes, IgG avidity and serotyped using strain-specific polymorphic peptides (GRA6 and GRA7). Our results suggest that IgG2 and IgG3 were associated with recent acquired infection. However, there is no association between isotypes and clinical evolution of OT, and also 6 different serotype-strains were detected in this population, but only one of these (Atypical D) was strongly associated with severe OT.

Streptococcus pneumoniae é uma bactéria encapsulada causadora de doenças infecciosas como pneumonia, bacteremia e meningite, infecções essas que estão entre as principais causas de morte entre crianças, idosos e imunodeprimidos, indivíduos que constituem o grupo de risco para tais infecções. A vacinação tem sido a mais eficaz forma de conter tais infecções. A vantagem das vacinas conjugadas em comparação às polissacarídicas é a capacidade de indução de uma resposta imune T-dependente o que garante proteção mesmo ao grupo de risco para infecções por S. pneumonia. A proposta do projeto foi estabelecer um protocolo para obtenção de um conjugado constituído pelo polissacarídeo capsular de S. pneumonia sorotipo 1 (PS1) e pela proteína de superfície pneumocócica A (PspA). A síntese do conjugado empregou uma metodologia inédita para o sorotipo 1. A avaliação da resposta imune humoral induzida pelo conjugado mostrou a indução de IgG anti-PS1 gerada pelas imunizações com o conjugado PS1-PspA. / Streptococcus pneumoniae is an encapsulated bacteria causing infectious diseases such as pneumonia, bacteremia and meningitis, these infections are among the leading causes of death among children, elderly and immunocompromised, who constituting individuals of risk group. The vaccination has been the more effective form to counter these infection. The advantage of conjugated vaccines compared to vaccines polysaccharide, is the ability to induce a T-dependent immune response which provides protection even at risk groups for infection by S. pneumoniae. The project proposal was establish a protocol for obtaining a conjugate consisting of the capsular polysaccharide of S. pneumoniae serotype 1 (PS1) and the pneumococcal surface protein A (PspA). The synthesis of conjugate employed a new methodology for serotype 1. The evaluation of humoral immune response induced by the conjugate showed anti-PS1 IgG induction generated by immunization with the PS1-PspA.

T. gondii é um protozoário amplamente disseminado pelo mundo que pode causar doença em animais e humanos. A evolução e a gravidade da doença dependem de características genéticas do parasita e do hospedeiro. A prevalência varia geograficamente, em Erechim, RS, 88% da população é soropositiva e 18% destes apresentam toxoplasmose ocular (TO). A resposta imune humoral contra T. gondii é persistente em todas as fases da infecção. O objetivo deste retrospectivo estudo foi correlacionar a imunidade humoral e a resposta contra peptídeos cepa-específicos com a gravidade da TO em pacientes de Erechim. 327 amostras de soro foram testadas (ELISA) para a pesquisa dos isótipos específicos e contra peptídeos cepa-específicos de regiões polimórficas (GRA6 e GRA7) do parasita. Nossos resultados sugerem que IgG2 e IgG3 estão associados à infecção adquirida recente, porém não há associação entre os isótipos e a evolução clínica da TO. Entretanto, embora seis diferentes sorotipos infectem estes pacientes, a gravidade da TO está associada a um novo padrão sorotípico (Atípico D). / T. gondii is a widespread protozoan parasite that is associated with a large spectrum of diseases in both humans and animals. The progression and severity of disease is quite variable and presumably due to some combination of host and parasite genetics. Prevalence varies with geography. In Erechim, Brazil, it is 88% prevalent and is related with a high incidence (18%) of ocular toxoplasmosis (OT). Humoral immune response against the parasite is effective. The aim of this retrospective study was to correlate the humoral immunity and response against the strain-specific peptides with the severity of the TO in Erechim`s patients. 327 sera were evaluated by ELISA to isotypes, IgG avidity and serotyped using strain-specific polymorphic peptides (GRA6 and GRA7). Our results suggest that IgG2 and IgG3 were associated with recent acquired infection. However, there is no association between isotypes and clinical evolution of OT, and also 6 different serotype-strains were detected in this population, but only one of these (Atypical D) was strongly associated with severe OT.

No description available.

Streptococcus pneumoniae é uma bactéria encapsulada causadora de doenças infecciosas como pneumonia, bacteremia e meningite, infecções essas que estão entre as principais causas de morte entre crianças, idosos e imunodeprimidos, indivíduos que constituem o grupo de risco para tais infecções. A vacinação tem sido a mais eficaz forma de conter tais infecções. A vantagem das vacinas conjugadas em comparação às polissacarídicas é a capacidade de indução de uma resposta imune T-dependente o que garante proteção mesmo ao grupo de risco para infecções por S. pneumonia. A proposta do projeto foi estabelecer um protocolo para obtenção de um conjugado constituído pelo polissacarídeo capsular de S. pneumonia sorotipo 1 (PS1) e pela proteína de superfície pneumocócica A (PspA). A síntese do conjugado empregou uma metodologia inédita para o sorotipo 1. A avaliação da resposta imune humoral induzida pelo conjugado mostrou a indução de IgG anti-PS1 gerada pelas imunizações com o conjugado PS1-PspA. / Streptococcus pneumoniae is an encapsulated bacteria causing infectious diseases such as pneumonia, bacteremia and meningitis, these infections are among the leading causes of death among children, elderly and immunocompromised, who constituting individuals of risk group. The vaccination has been the more effective form to counter these infection. The advantage of conjugated vaccines compared to vaccines polysaccharide, is the ability to induce a T-dependent immune response which provides protection even at risk groups for infection by S. pneumoniae. The project proposal was establish a protocol for obtaining a conjugate consisting of the capsular polysaccharide of S. pneumoniae serotype 1 (PS1) and the pneumococcal surface protein A (PspA). The synthesis of conjugate employed a new methodology for serotype 1. The evaluation of humoral immune response induced by the conjugate showed anti-PS1 IgG induction generated by immunization with the PS1-PspA.

Toll like receptors (TLRs) are found on B cells, macrophages, monocytes, and dendritic cells, and these cells belong to the innate immune system that recognizes antigens and induces multiple cell responses through the release of cytokines. TLR1, TLR2 and TLR6 function as heterodimers, either as TLR1/TLR2 or TLR2/TLR6 to recognize lipopeptides. TLR1/2 dimer activation releases inflammatory cytokines, while TLR2/TLR6 dimer activation releases immunomodulatory cytokines. Based on the size of the binding pocket between TLR2 and TLR6, it was hypothesized that lipopeptides, such as FSL1, could be simplified while keeping overall activity. FSL1 is a lipopeptide first isolated from Mycoplasma salivarum that activates macrophages at picomolar concentrations. It is expected that synthetic lipopeptides mimicking immunostimulatory molecules such as FSL1 will allow development of better ways to stimulate or modulate the immune system. Therefore, novel synthetic TLR2/6 ligands were synthesized replacing the polylysine chain with a polyamine chain showing activation of the immune cells in a manner like FSL1. Natural killer T-cell (NKT) antigens, such as α-galactosylceramide (α-GalCer), are carried through the body by lipid transfer proteins before they interact with the NKT cells. Not all the proteins involved in glycolipid transportation have been characterized. The synthesis of an α-GalCer analogue, termed CD1d-Triceps was designed to help find additional proteins involved in glycolipid trafficking. CD1d-Triceps has three functionalities: the first is the α-GalCer structure, and the other two are on C6 of the sugar: biotin, which helps tag the molecule for its purification, and a photoactive tag that, upon UV light activation, will cross-link with neighboring proteins. Antibiotic-resistant strains of Staphylococcus aureus (SA) are a growing health problem worldwide. Serotype 5 and 8 are the most common SA pathogens. Loading the serotype 5 or 8 disaccharides onto Qβ-particles that are linked to an NKT cell activator yield a vaccine that is expected to trigger adaptive immunity to the disaccharide. Previous similar studies showed production of antibodies with high affinity against Streptococcus pyogenes oligosaccharides in a similar vaccine.

Indiana University-Purdue University Indianapolis (IUPUI) / High-efficiency transduction of hematopoietic stem cells (HSCs) by recombinant adeno-associated virus serotype 2 (AAV2) vectors is limited by (i) inadequate expression of cellular receptor/co-receptors for AAV2; (ii) impaired intracellular trafficking and uncoating in the nucleus; (iii) failure of the genome to undergo second-strand DNA synthesis; and (iv) use of sub-optimal promoters. Systematic studies were undertaken to develop alternative strategies to achieve high-efficiency transduction of primary murine HSCs and lineage-restricted transgene expression in a bone marrow transplant model in vivo. These included the use of: (i) additional AAV serotype (AAV1, AAV7, AAV8, AAV10) vectors; (ii) self-complementary AAV (scAAV) vectors; and (iii) erythroid cell-specific promoters. scAAV1 and scAAV7 vectors containing an enhanced green-fluorescent protein (EGFP) reporter gene under the control of hematopoietic cell-specific enhancers/promoters allowed sustained transgene expression in an erythroid lineage-restricted manner in both primary and secondary transplant recipient mice. Self complementary AAV vectors containing an anti-sickling human beta-globin gene under the control of either the beta-globin gene promoter/enhancer, or the human parvovirus B19 promoter at map-unit 6 (B19p6) were tested for their efficacy in a human erythroid cell line (K562), and in primary murine hematopoietic progenitor cells (c-kit+, lin-). These studies revealed that (i) scAAV2-beta-globin vectors containing only the HS2 enhancer are more efficient than ssAAV2-beta-globin vectors containing the HS2+HS3+HS4 enhancers; (ii) scAAV-beta-globin vectors containing only the B19p6 promoter are more efficient than their counterparts containing the HS2 enhancer/beta-globin promoter; and (iii) scAAV2-B19p6-beta-globin vectors in K562 cells, and scAAV1-B19p6-beta-globin vectors in murine c-kit+, lin- cells, yield efficient expression of the beta-globin protein. These studies suggest that the combined use of scAAV serotype vectors and the B19p6 promoter may lead to expression of therapeutic levels of beta-globin gene in human erythroid cells, which has implications in the potential gene therapy of beta-thalassemia and sickle cell disease.

No description available.

No description available.